Prot# DS1040-B-U107: A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multi- Center, Single Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of DS-1040b when Added to Standard of Care Anticoagulati

Project: Research project

Project Details

StatusActive
Effective start/end date10/10/1710/10/20

Funding

  • Daiichi Sankyo, Inc. (Prot# DS1040-B-U107)